Correlation Between Fiducial Office and Acticor Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fiducial Office and Acticor Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fiducial Office and Acticor Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fiducial Office Solutions and Acticor Biotech SAS, you can compare the effects of market volatilities on Fiducial Office and Acticor Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fiducial Office with a short position of Acticor Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fiducial Office and Acticor Biotech.

Diversification Opportunities for Fiducial Office and Acticor Biotech

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Fiducial and Acticor is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Fiducial Office Solutions and Acticor Biotech SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acticor Biotech SAS and Fiducial Office is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fiducial Office Solutions are associated (or correlated) with Acticor Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acticor Biotech SAS has no effect on the direction of Fiducial Office i.e., Fiducial Office and Acticor Biotech go up and down completely randomly.

Pair Corralation between Fiducial Office and Acticor Biotech

Assuming the 90 days trading horizon Fiducial Office Solutions is expected to generate 0.07 times more return on investment than Acticor Biotech. However, Fiducial Office Solutions is 13.97 times less risky than Acticor Biotech. It trades about 0.0 of its potential returns per unit of risk. Acticor Biotech SAS is currently generating about -0.27 per unit of risk. If you would invest  2,800  in Fiducial Office Solutions on September 14, 2024 and sell it today you would earn a total of  0.00  from holding Fiducial Office Solutions or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Fiducial Office Solutions  vs.  Acticor Biotech SAS

 Performance 
       Timeline  
Fiducial Office Solutions 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Fiducial Office Solutions are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Fiducial Office is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Acticor Biotech SAS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Fiducial Office and Acticor Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fiducial Office and Acticor Biotech

The main advantage of trading using opposite Fiducial Office and Acticor Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fiducial Office position performs unexpectedly, Acticor Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acticor Biotech will offset losses from the drop in Acticor Biotech's long position.
The idea behind Fiducial Office Solutions and Acticor Biotech SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements